{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:54:49Z","timestamp":1793652889915,"version":"4.5.1"},"reference-count":185,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071749"],"award-info":[{"award-number":["82071749"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.phrs.2024.107155","type":"journal-article","created":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T09:24:31Z","timestamp":1711185871000},"page":"107155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"special_numbering":"C","title":["SIRT1: Harnessing multiple pathways to hinder NAFLD"],"prefix":"10.1016","volume":"203","author":[{"given":"Cheng","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2024.107155_bib1","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2024.107155_bib2","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S2468-1253(23)00159-0","article-title":"NASH drug treatment development: challenges and lessons","volume":"8","author":"Tilg","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2024.107155_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119388","article-title":"Responsive oligochitosan nano-vesicles with ursodeoxycholic acid and exenatide for NAFLD synergistic therapy via SIRT1","volume":"288","author":"Xie","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.phrs.2024.107155_bib4","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1172\/JCI97831","article-title":"G\u03b112 ablation exacerbates liver steatosis and obesity by suppressing USP22\/SIRT1-regulated mitochondrial respiration","volume":"128","author":"Kim","year":"2018","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.phrs.2024.107155_bib5","article-title":"SIRT1\/SREBPs-mediated regulation of lipid metabolism","volume":"199","author":"Shen","year":"2023","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phrs.2024.107155_bib6","article-title":"Regulation of SIRT1 and its roles in inflammation","volume":"13","author":"Yang","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.phrs.2024.107155_bib7","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s10753-020-01242-9","article-title":"Role of silent information regulator 1 (SIRT1) in regulating oxidative stress and inflammation","volume":"43","author":"Singh","year":"2020","journal-title":"Inflammation"},{"key":"10.1016\/j.phrs.2024.107155_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103692","article-title":"Targeting SIRT1-regulated autophagic cell death as a novel therapeutic avenue for cancer prevention","volume":"28","author":"Patra","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.phrs.2024.107155_bib9","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7150\/ijbs.78654","article-title":"Novel role of the SIRT1 in endocrine and metabolic diseases","volume":"19","author":"Lu","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.phrs.2024.107155_bib10","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jmb.2013.10.009","article-title":"Structural and functional analysis of human SIRT1","volume":"426","author":"Davenport","year":"2014","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.phrs.2024.107155_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1478-811X-9-11","article-title":"Mammalian Sirt1: insights on its biological functions","volume":"9","author":"Rahman","year":"2011","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.phrs.2024.107155_bib12","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/j.apsb.2023.02.018","article-title":"Nimbolide targeting SIRT1 mitigates intervertebral disc degeneration by reprogramming cholesterol metabolism and inhibiting inflammatory signaling","volume":"13","author":"Teng","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phrs.2024.107155_bib13","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1093\/cvr\/cvad102","article-title":"Chronic SIRT1 supplementation in diabetic mice improves endothelial function by suppressing oxidative stress","volume":"119","author":"Yang","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.phrs.2024.107155_bib14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrm3293","article-title":"Sirtuins as regulators of metabolism and healthspan","volume":"13","author":"Houtkooper","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.phrs.2024.107155_bib15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cmet.2019.06.017","article-title":"Generation of human fatty livers using custom-engineered induced pluripotent stem cells with modifiable SIRT1 metabolism","volume":"30","author":"Collin de l\u2032Hortet","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2024.107155_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cmet.2005.07.001","article-title":"Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice","volume":"2","author":"Moynihan","year":"2005","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2024.107155_bib17","article-title":"Decoupling NAD(+) metabolic dependency in chondrosarcoma by targeting the SIRT1-HIF-2\u03b1 axis.","author":"Suh","year":"2023","journal-title":"Cell Rep. Med"},{"key":"10.1016\/j.phrs.2024.107155_bib18","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1038\/sj.emboj.7600244","article-title":"Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase.","volume":"23","author":"Yeung","year":"2004","journal-title":"Embo J."},{"key":"10.1016\/j.phrs.2024.107155_bib19","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.molcel.2010.05.023","article-title":"Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha","volume":"38","author":"Lim","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2024.107155_bib20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0092-8674(01)00527-X","article-title":"hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase","volume":"107","author":"Vaziri","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2024.107155_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1039726","article-title":"Mouse promyelocytic leukemia zinc finger protein (PLZF) regulates hepatic lipid and glucose homeostasis dependent on SIRT1","volume":"13","author":"Hu","year":"2022","journal-title":"Front Pharm."},{"key":"10.1016\/j.phrs.2024.107155_bib22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.freeradbiomed.2022.09.020","article-title":"Autophagy promotes directed migration of HUVEC in response to electric fields through the ROS\/SIRT1\/FOXO1 pathway","volume":"192","author":"Li","year":"2022","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.phrs.2024.107155_bib23","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13578-023-01130-3","article-title":"NADH elevation during chronic hypoxia leads to VHL-mediated HIF-1\u03b1 degradation via SIRT1 inhibition","volume":"13","author":"Joo","year":"2023","journal-title":"Cell Biosci."},{"key":"10.1016\/j.phrs.2024.107155_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.930919","article-title":"SIRT1 and autophagy: implications in endocrine disorders","volume":"13","author":"Kim","year":"2022","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.phrs.2024.107155_bib25","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.molcel.2014.12.013","article-title":"Deacetylation of nuclear LC3 drives autophagy initiation under starvation","volume":"57","author":"Huang","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2024.107155_bib26","article-title":"Berberine alleviates non-alcoholic hepatic steatosis partially by promoting SIRT1 deacetylation of CPT1A in mice","volume":"11","author":"Wang","year":"2023","journal-title":"Gastroenterol. Rep. (Oxf.)"},{"key":"10.1016\/j.phrs.2024.107155_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102334","article-title":"Inhibition of nuclear deacetylase Sirtuin-1 induces mitochondrial acetylation and calcium overload leading to cell death","volume":"53","author":"Sun","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.phrs.2024.107155_bib28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13148-019-0806-y","article-title":"DNA hypermethylation of sirtuin 1 (SIRT1) caused by betel quid chewing-a possible predictive biomarker for malignant transformation","volume":"12","author":"Islam","year":"2020","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.phrs.2024.107155_bib29","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.7150\/ijbs.33044","article-title":"Epigenetic down-regulation of Sirt 1 via DNA methylation and oxidative stress signaling contributes to the gestational diabetes mellitus-induced fetal programming of heart ischemia-sensitive phenotype in late life","volume":"15","author":"Chen","year":"2019","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.phrs.2024.107155_bib30","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/s12276-021-00628-5","article-title":"Proto-oncoprotein Zbtb7c and SIRT1 repression: implications in high-fat diet-induced and age-dependent obesity","volume":"53","author":"Choi","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.phrs.2024.107155_bib31","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/s41419-021-04185-7","article-title":"FBXW11 contributes to stem-cell-like features and liver metastasis through regulating HIC1-mediated SIRT1 transcription in colorectal cancer","volume":"12","author":"Yao","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2024.107155_bib32","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.stem.2014.08.001","article-title":"SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells","volume":"15","author":"Li","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.phrs.2024.107155_bib33","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/ncb1468","article-title":"Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage","volume":"8","author":"Wang","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.phrs.2024.107155_bib34","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1126\/science.1101731","article-title":"Nutrient availability regulates SIRT1 through a forkhead-dependent pathway","volume":"306","author":"Nemoto","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.phrs.2024.107155_bib35","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1128\/MCB.01098-06","article-title":"An acetylation\/deacetylation-SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity","volume":"27","author":"Stankovic-Valentin","year":"2007","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.phrs.2024.107155_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13866","article-title":"Sirt1 regulates glial progenitor proliferation and regeneration in white matter after neonatal brain injury","volume":"7","author":"Jablonska","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2024.107155_bib37","article-title":"CHFR negatively regulates SIRT1 activity upon oxidative stress","volume":"6","author":"Kim","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2024.107155_bib38","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1038\/s41388-020-1298-0","article-title":"Ubiquitination-mediated degradation of SIRT1 by SMURF2 suppresses CRC cell proliferation and tumorigenesis","volume":"39","author":"Yu","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2024.107155_bib39","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/s12276-023-01012-1","article-title":"SIRT1 ubiquitination is regulated by opposing activities of APC\/C-Cdh1 and AROS during stress-induced premature senescence","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.phrs.2024.107155_bib40","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13045-018-0638-9","article-title":"Ube2v1-mediated ubiquitination and degradation of Sirt1 promotes metastasis of colorectal cancer by epigenetically suppressing autophagy","volume":"11","author":"Shen","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.phrs.2024.107155_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155579","article-title":"DR region of NKA\u03b11 is a target to ameliorate hepatic lipid metabolism disturbance in obese mice","volume":"145","author":"Sun","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.phrs.2024.107155_bib42","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1038\/s41418-022-00952-x","article-title":"Regulation of sclerostin by the SIRT1 stabilization pathway in osteocytes","volume":"29","author":"Kim","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.phrs.2024.107155_bib43","doi-asserted-by":"crossref","first-page":"8904","DOI":"10.1074\/jbc.M114.612796","article-title":"Ubiquitinated sirtuin 1 (SIRT1) function is modulated during DNA damage-induced cell death and survival","volume":"290","author":"Peng","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2024.107155_bib44","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijbiomac.2021.08.013","article-title":"A review study on the modulation of SIRT1 expression by miRNAs in aging and age-associated diseases","volume":"188","author":"Zia","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.phrs.2024.107155_bib45","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1093\/nar\/gkq227","article-title":"Transcriptional corepressor SHP recruits SIRT1 histone deacetylase to inhibit LRH-1 transactivation","volume":"38","author":"Chanda","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phrs.2024.107155_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114515","article-title":"Quercetin activates the Sestrin2\/AMPK\/SIRT1 axis to improve amyotrophic lateral sclerosis","volume":"161","author":"Jin","year":"2023","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.phrs.2024.107155_bib47","doi-asserted-by":"crossref","first-page":"23489","DOI":"10.1074\/jbc.M112.365874","article-title":"Role of deleted in breast cancer 1 (DBC1) protein in SIRT1 deacetylase activation induced by protein kinase A and AMP-activated protein kinase","volume":"287","author":"Nin","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2024.107155_bib48","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jhep.2013.07.011","article-title":"Hepatic menin recruits SIRT1 to control liver steatosis through histone deacetylation","volume":"59","author":"Cao","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2024.107155_bib49","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/ncb1645","article-title":"SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress","volume":"9","author":"Yang","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.phrs.2024.107155_bib50","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nature06500","article-title":"DBC1 is a negative regulator of SIRT1","volume":"451","author":"Kim","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107155_bib51","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cmet.2011.03.004","article-title":"PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation","volume":"13","author":"Bai","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2024.107155_bib52","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.cmet.2011.03.013","article-title":"PARP-2 regulates SIRT1 expression and whole-body energy expenditure","volume":"13","author":"Bai","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2024.107155_bib53","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41419-021-03608-9","article-title":"E3 ubiquitin ligase Grail promotes hepatic steatosis through Sirt1 inhibition","volume":"12","author":"Liu","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2024.107155_bib54","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00006-17","article-title":"Obesity-linked phosphorylation of SIRT1 by casein kinase 2 inhibits its nuclear localization and promotes fatty liver","volume":"37","author":"Choi","year":"2017","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.phrs.2024.107155_bib55","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41574-021-00507-z","article-title":"Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus","volume":"17","author":"Ferguson","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.phrs.2024.107155_bib56","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.jhep.2020.02.020","article-title":"Update on NAFLD genetics: From new variants to the clinic","volume":"72","author":"Tr\u00e9po","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2024.107155_bib57","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med"},{"key":"10.1016\/j.phrs.2024.107155_bib58","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.jhep.2013.07.027","article-title":"Adipose tissue and liver expression of SIRT1, 3, and 6 increase after extensive weight loss in morbid obesity","volume":"59","author":"Moschen","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2024.107155_bib59","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s12020-014-0465-x","article-title":"Plasma levels of SIRT1 associate with non-alcoholic fatty liver disease in obese patients","volume":"49","author":"Mariani","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.phrs.2024.107155_bib60","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12072-017-9836-8","article-title":"Association of SIRT1 gene polymorphism and its expression for the risk of alcoholic fatty liver disease in the Han population","volume":"12","author":"Hou","year":"2018","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.phrs.2024.107155_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114987","article-title":"Alternative pathway of bile acid biosynthesis contributes to ameliorate NASH after induction of NAMPT\/NAD(+)\/SIRT1 axis","volume":"164","author":"Yang","year":"2023","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.phrs.2024.107155_bib62","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.7150\/ijbs.68873","article-title":"Atractylenolide III ameliorates non-alcoholic fatty liver disease by activating hepatic adiponectin receptor 1-mediated AMPK pathway","volume":"18","author":"Li","year":"2022","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.phrs.2024.107155_bib63","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/hep.28245","article-title":"Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice","volume":"63","author":"Gariani","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2024.107155_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.560905","article-title":"Activation of the AMPK-SIRT1 pathway contributes to protective effects of Salvianolic acid A against lipotoxicity in hepatocytes and NAFLD in mice","volume":"11","author":"Li","year":"2020","journal-title":"Front Pharm."},{"key":"10.1016\/j.phrs.2024.107155_bib65","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.metabol.2018.10.004","article-title":"Adiponectin homolog novel osmotin protects obesity\/diabetes-induced NAFLD by upregulating AdipoRs\/PPAR\u03b1 signaling in ob\/ob and db\/db transgenic mouse models","volume":"90","author":"Ahmad","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.phrs.2024.107155_bib66","doi-asserted-by":"crossref","first-page":"13992","DOI":"10.1021\/acs.est.9b05131","article-title":"Inhibition of mitochondrial fatty acid oxidation contributes to development of nonalcoholic fatty liver disease induced by environmental cadmium exposure","volume":"53","author":"He","year":"2019","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.phrs.2024.107155_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2021.147182","article-title":"Cadmium chloride induces non-alcoholic fatty liver disease in rats by stimulating miR-34a\/SIRT1\/FXR\/p53 axis","volume":"784","author":"Alshehri","year":"2021","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.phrs.2024.107155_bib68","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/path.5548","article-title":"Differential TM4SF5-mediated SIRT1 modulation and metabolic signaling in nonalcoholic steatohepatitis progression","volume":"253","author":"Ryu","year":"2021","journal-title":"J. Pathol."},{"key":"10.1016\/j.phrs.2024.107155_bib69","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jhep.2021.06.045","article-title":"Maternal obesity increases the risk and severity of NAFLD in offspring","volume":"75","author":"Hagstr\u00f6m","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2024.107155_bib70","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1113\/JP276957","article-title":"SIRT1 overexpression attenuates offspring metabolic and liver disorders as a result of maternal high-fat feeding","volume":"597","author":"Nguyen","year":"2019","journal-title":"J. Physiol."},{"key":"10.1016\/j.phrs.2024.107155_bib71","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1021\/acs.jafc.2c01461","article-title":"The ameliorating effects of apple polyphenol extract on high-fat-diet-induced hepatic steatosis are SIRT1-dependent: evidence from hepatic-specific SIRT1 heterozygous mutant C57BL\/6 mice","volume":"70","author":"Yin","year":"2022","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.phrs.2024.107155_bib72","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1016\/j.bbadis.2017.08.004","article-title":"Ablation of systemic SIRT1 activity promotes nonalcoholic fatty liver disease by affecting liver-mesenteric adipose tissue fatty acid mobilization","volume":"1863","author":"Cheng","year":"2017","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.phrs.2024.107155_bib73","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2014.39","article-title":"AAV8-mediated Sirt1 gene transfer to the liver prevents high carbohydrate diet-induced nonalcoholic fatty liver disease","volume":"1","author":"Vil\u00e0","year":"2014","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.phrs.2024.107155_bib74","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.3390\/cimb45060321","article-title":"SIRT1 activator E1231 alleviates nonalcoholic fatty liver disease by regulating lipid metabolism","volume":"45","author":"Han","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.phrs.2024.107155_bib75","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1002\/ptr.7101","article-title":"Administration of isoliquiritigenin prevents nonalcoholic fatty liver disease through a novel IQGAP2-CREB-SIRT1 axis","volume":"35","author":"Zhang","year":"2021","journal-title":"Phytother. Res"},{"key":"10.1016\/j.phrs.2024.107155_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114319","article-title":"Protopanaxadiol ameliorates NAFLD by regulating hepatocyte lipid metabolism through AMPK\/SIRT1 signaling pathway","volume":"160","author":"Li","year":"2023","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.phrs.2024.107155_bib77","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.2337\/db14-0263","article-title":"SIRT1 mediates the effect of GLP-1 receptor agonist exenatide on ameliorating hepatic steatosis","volume":"63","author":"Xu","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2024.107155_bib78","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13578-020-00477-1","article-title":"Phloretin ameliorates hepatic steatosis through regulation of lipogenesis and Sirt1\/AMPK signaling in obese mice","volume":"10","author":"Liou","year":"2020","journal-title":"Cell Biosci."},{"key":"10.1016\/j.phrs.2024.107155_bib79","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1002\/ptr.7526","article-title":"Puerarin attenuates hepatic steatosis via G-protein-coupled estrogen receptor-mediated calcium and SIRT1 signaling pathways","volume":"36","author":"Pham","year":"2022","journal-title":"Phytother. Res"},{"key":"10.1016\/j.phrs.2024.107155_bib80","doi-asserted-by":"crossref","first-page":"472","DOI":"10.7150\/ijbs.10809","article-title":"Stem cell transplantation upregulates Sirt1 and antioxidant expression, ameliorating fatty liver in type 2 diabetic mice","volume":"11","author":"Li","year":"2015","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.phrs.2024.107155_bib81","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.1093\/eurheartj\/ehad661","article-title":"Actionable autophagy checkpoints in cardiovascular ageing","volume":"44","author":"Abdellatif","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2024.107155_bib82","first-page":"1","article-title":"Dysfunction of autophagy in high-fat diet-induced nonalcoholic fatty liver disease","author":"Ren","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.phrs.2024.107155_bib83","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jhep.2017.02.037","article-title":"The IRGM rs10065172 variant increases the risk for steatosis but not for liver damage progression in Italian obese children","volume":"67","author":"Bellini","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2024.107155_bib84","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jhep.2022.03.031","article-title":"Rare ATG7 genetic variants predispose patients to severe fatty liver disease","volume":"77","author":"Baselli","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2024.107155_bib85","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41467-020-14384-z","article-title":"Fasting-induced FGF21 signaling activates hepatic autophagy and lipid degradation via JMJD3 histone demethylase","volume":"11","author":"Byun","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2024.107155_bib86","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1080\/15548627.2020.1712108","article-title":"SQSTM1\/p62 activates NFE2L2\/NRF2 via ULK1-mediated autophagic KEAP1 degradation and protects mouse liver from lipotoxicity","volume":"16","author":"Lee","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.phrs.2024.107155_bib87","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1080\/15548627.2018.1490850","article-title":"Dynamic MTORC1-TFEB feedback signaling regulates hepatic autophagy, steatosis and liver injury in long-term nutrient oversupply","volume":"14","author":"Zhang","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.phrs.2024.107155_bib88","article-title":"SIRT1 is a regulator of autophagy: implications for the progression and treatment of myocardial ischemia-reperfusion","volume":"199","author":"Ding","year":"2023","journal-title":"Pharm. Res"},{"key":"10.1016\/j.phrs.2024.107155_bib89","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/15548627.2020.1860541","article-title":"SIRT1 - a new mammalian substrate of nuclear autophagy","volume":"17","author":"Wang","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.phrs.2024.107155_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18051063","article-title":"Ginsenoside Rb2 alleviates hepatic lipid accumulation by restoring autophagy via induction of Sirt1 and activation of AMPK","volume":"18","author":"Huang","year":"2017","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107155_bib91","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.nutres.2017.03.005","article-title":"Nicotinamide protects hepatocytes against palmitate-induced lipotoxicity via SIRT1-dependent autophagy induction","volume":"40","author":"Shen","year":"2017","journal-title":"Nutr. Res"},{"key":"10.1016\/j.phrs.2024.107155_bib92","article-title":"COX-2\/sEH dual inhibitor alleviates hepatocyte senescence in NAFLD mice by restoring autophagy through Sirt1\/PI3K\/AKT\/mTOR","volume":"23","author":"Zhang","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107155_bib93","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4161\/15548627.2014.984271","article-title":"Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway","volume":"11","author":"Song","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.phrs.2024.107155_bib94","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3389\/fphys.2019.00494","article-title":"Tangshen formula alleviates hepatic steatosis by inducing autophagy through the AMPK\/SIRT1 pathway","volume":"10","author":"Wang","year":"2019","journal-title":"Front Physiol."},{"key":"10.1016\/j.phrs.2024.107155_bib95","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/ptr.6902","article-title":"Apple polyphenol extract alleviates lipid accumulation in free-fatty-acid-exposed HepG2 cells via activating autophagy mediated by SIRT1\/AMPK signaling","volume":"35","author":"Li","year":"2021","journal-title":"Phytother. Res"},{"key":"10.1016\/j.phrs.2024.107155_bib96","doi-asserted-by":"crossref","DOI":"10.3390\/cells8091053","article-title":"Melatonin effects on non-alcoholic fatty liver disease are related to MicroRNA-34a-5p\/Sirt1 axis and autophagy","volume":"8","author":"Stacchiotti","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2024.107155_bib97","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhep.2022.09.020","article-title":"Mitochondrial alterations in fatty liver diseases","volume":"78","author":"Fromenty","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2024.107155_bib98","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","article-title":"Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis","volume":"21","author":"Koliaki","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2024.107155_bib99","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/j.gastro.2018.06.083","article-title":"Mitochondrial Dysfunction and Signaling in Chronic Liver Diseases","volume":"155","author":"Mansouri","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2024.107155_bib100","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/gutjnl-2012-302962","article-title":"Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease","volume":"62","author":"Pirola","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.phrs.2024.107155_bib101","doi-asserted-by":"crossref","DOI":"10.3390\/biom12081079","article-title":"Progress in nonalcoholic fatty liver disease: SIRT family regulates mitochondrial biogenesis","volume":"12","author":"Zeng","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.phrs.2024.107155_bib102","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2006.11.013","article-title":"Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha","volume":"127","author":"Lagouge","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2024.107155_bib103","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12491","article-title":"Melatonin prevents Drp1-mediated mitochondrial fission in diabetic hearts through SIRT1-PGC1\u03b1 pathway","volume":"65","author":"Ding","year":"2018","journal-title":"J. Pineal Res"},{"key":"10.1016\/j.phrs.2024.107155_bib104","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jhep.2021.09.008","article-title":"Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function","volume":"76","author":"da Silva Lima","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2024.107155_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115728","article-title":"SIRT1-dependent mitochondrial biogenesis supports therapeutic effects of 4-butyl-polyhydroxybenzophenone compounds against NAFLD","volume":"260","author":"Song","year":"2023","journal-title":"Eur. J. Med Chem."},{"key":"10.1016\/j.phrs.2024.107155_bib106","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1007\/s11427-016-9027-6","article-title":"Retinoic acid ameliorates high-fat diet-induced liver steatosis through sirt1","volume":"60","author":"Geng","year":"2017","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.phrs.2024.107155_bib107","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1039\/C8FO02298D","article-title":"Protection of hepatocyte mitochondrial function by blueberry juice and probiotics via SIRT1 regulation in non-alcoholic fatty liver disease","volume":"10","author":"Ren","year":"2019","journal-title":"Food Funct."},{"key":"10.1016\/j.phrs.2024.107155_bib108","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12944-023-01798-z","article-title":"Exercise activates Sirt1-mediated Drp1 acetylation and inhibits hepatocyte apoptosis to improve nonalcoholic fatty liver disease","volume":"22","author":"Hu","year":"2023","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.phrs.2024.107155_bib109","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.phrs.2024.107155_bib110","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.phrs.2024.107155_bib111","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12690","article-title":"Melatonin protects mouse testes from palmitic acid-induced lipotoxicity by attenuating oxidative stress and DNA damage in a SIRT1-dependent manner","volume":"69","author":"Xu","year":"2020","journal-title":"J. Pineal Res"},{"key":"10.1016\/j.phrs.2024.107155_bib112","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12967-022-03408-5","article-title":"SIRT1 prevents cigarette smoking-induced lung fibroblasts activation by regulating mitochondrial oxidative stress and lipid metabolism","volume":"20","author":"Zhang","year":"2022","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.phrs.2024.107155_bib113","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.ijbiomac.2018.02.072","article-title":"Low molecular weight fucoidan attenuates liver injury via SIRT1\/AMPK\/PGC1\u03b1 axis in db\/db mice","volume":"112","author":"Zheng","year":"2018","journal-title":"Int J. Biol. Macromol."},{"key":"10.1016\/j.phrs.2024.107155_bib114","article-title":"Exogenous hydrogen sulfide alleviates hepatic endoplasmic reticulum stress via SIRT1\/FoxO1\/PCSK9 pathway in NAFLD. Faseb j","volume":"37","author":"Cui","year":"2023"},{"key":"10.1016\/j.phrs.2024.107155_bib115","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1021\/acs.jafc.0c00833","article-title":"Ginsenoside Rg2 Ameliorates High-Fat Diet-Induced Metabolic Disease through SIRT1","volume":"68","author":"Cheng","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.phrs.2024.107155_bib116","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1001778","article-title":"Yinchen Linggui Zhugan decoction ameliorates high fat diet-induced nonalcoholic fatty liver disease by modulation of SIRT1\/Nrf2 signaling pathway and gut microbiota","volume":"13","author":"Jiang","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.phrs.2024.107155_bib117","article-title":"Pharmacologic inhibition of lipogenesis for the treatment of NAFLD","author":"Esler","year":"2023","journal-title":"J. Hepatol., ("},{"key":"10.1016\/j.phrs.2024.107155_bib118","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12944-017-0464-z","article-title":"Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1\/AMPK\u03b1\/SREBP1 signaling pathway","volume":"16","author":"Wang","year":"2017","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.phrs.2024.107155_bib119","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.1021\/acs.jafc.2c00641","article-title":"Pterostilbene and Its Derivative 3\u2032-Hydroxypterostilbene Ameliorated Nonalcoholic Fatty Liver Disease Through Synergistic Modulation of the Gut Microbiota and SIRT1\/AMPK Signaling Pathway","volume":"70","author":"Tsai","year":"2022","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.phrs.2024.107155_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113927","article-title":"Modulation of SIRT1-mediated signaling cascades in the liver contributes to the amelioration of nonalcoholic steatohepatitis in high fat fed middle-aged LDL receptor knockout mice by dihydromyricetin","volume":"175","author":"Zeng","year":"2020","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.phrs.2024.107155_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153412","article-title":"Naringenin alleviates nonalcoholic steatohepatitis in middle-aged Apoe(-\/-)mice: role of SIRT1.","volume":"81","author":"Hua","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phrs.2024.107155_bib122","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41423-020-00579-3","article-title":"Immunological mechanisms and therapeutic targets of fatty liver diseases","volume":"18","author":"Wang","year":"2021","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.phrs.2024.107155_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106092","article-title":"Kinsenoside attenuates liver fibro-inflammation by suppressing dendritic cells via the PI3K-AKT-FoxO1 pathway","volume":"177","author":"Xiang","year":"2022","journal-title":"Pharm. Res"},{"key":"10.1016\/j.phrs.2024.107155_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111274","article-title":"Melatonin attenuates oxidative stress and inflammation of M\u00fcller cells in diabetic retinopathy via activating the Sirt1 pathway","volume":"137","author":"Tu","year":"2021","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.phrs.2024.107155_bib125","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1080\/13880209.2021.1945112","article-title":"Esculin protects against methionine choline-deficient diet-induced non-alcoholic steatohepatitis by regulating the Sirt1\/NF-\u03baB p65 pathway","volume":"59","author":"Yang","year":"2021","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.phrs.2024.107155_bib126","first-page":"1609","article-title":"SIRT1 upregulation protects against liver injury induced by a HFD through inhibiting CD36 and the NF\u2011\u03baB pathway in mouse kupffer cells","volume":"18","author":"Niu","year":"2018","journal-title":"Mol. Med Rep."},{"key":"10.1016\/j.phrs.2024.107155_bib127","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jhep.2012.08.008","article-title":"miR-34a\/SIRT1\/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease","volume":"58","author":"Castro","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2024.107155_bib128","first-page":"1271","article-title":"SIRT1 mediates the role of RNA-binding protein QKI 5 in the synthesis of triglycerides in non-alcoholic fatty liver disease mice via the PPAR\u03b1\/FoxO1 signaling pathway","volume":"43","author":"Zhang","year":"2019","journal-title":"Int J. Mol. Med"},{"key":"10.1016\/j.phrs.2024.107155_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155516","article-title":"Metformin-induced TTP mediates communication between Kupffer cells and hepatocytes to alleviate hepatic steatosis by regulating lipophagy and necroptosis","volume":"141","author":"Park","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.phrs.2024.107155_bib130","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.196","article-title":"Activation of the SIRT1\/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease","volume":"6","author":"Shan","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2024.107155_bib131","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.791861","article-title":"Sirt1 promotes the restoration of hepatic progenitor cell (HPC)-mediated liver fatty injury in NAFLD through activating the Wnt\/\u03b2-catenin signal pathway","volume":"8","author":"Li","year":"2021","journal-title":"Front Nutr."},{"key":"10.1016\/j.phrs.2024.107155_bib132","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature01960","article-title":"Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan","volume":"425","author":"Howitz","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107155_bib133","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/mnfr.201500016","article-title":"Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway","volume":"59","author":"Zhang","year":"2015","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.phrs.2024.107155_bib134","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1039\/D0FO01459A","article-title":"Improvement of the hepatic lipid status in intrauterine growth retarded pigs by resveratrol is related to the inhibition of mitochondrial dysfunction, oxidative stress and inflammation","volume":"12","author":"Cheng","year":"2021","journal-title":"Food Funct."},{"key":"10.1016\/j.phrs.2024.107155_bib135","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1743-7075-11-35","article-title":"Effects and mechanisms of resveratrol on the amelioration of oxidative stress and hepatic steatosis in KKAy mice","volume":"11","author":"Zhu","year":"2014","journal-title":"Nutr. Metab. (Lond. )"},{"key":"10.1016\/j.phrs.2024.107155_bib136","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11010-016-2807-x","article-title":"Resveratrol supplement inhibited the NF-\u03baB inflammation pathway through activating AMPK\u03b1-SIRT1 pathway in mice with fatty liver","volume":"422","author":"Tian","year":"2016","journal-title":"Mol. Cell Biochem"},{"key":"10.1016\/j.phrs.2024.107155_bib137","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.fct.2012.10.026","article-title":"Alleviative effects of resveratrol on nonalcoholic fatty liver disease are associated with up regulation of hepatic low density lipoprotein receptor and scavenger receptor class B type I gene expressions in rats","volume":"52","author":"Xin","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.phrs.2024.107155_bib138","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.phrs.2015.03.005","article-title":"Effect of resveratrol on experimental non-alcoholic steatohepatitis","volume":"95-96","author":"Heeb\u00f8ll","year":"2015","journal-title":"Pharm. Res"},{"key":"10.1016\/j.phrs.2024.107155_bib139","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.dld.2014.11.015","article-title":"Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial","volume":"47","author":"Chen","year":"2015","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.phrs.2024.107155_bib140","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1024\/0300-9831\/a000528","article-title":"No beneficial effects of resveratrol supplementation on atherogenic risk factors in patients with nonalcoholic fatty liver disease","volume":"90","author":"Farzin","year":"2020","journal-title":"Int J. Vitam. Nutr. Res"},{"key":"10.1016\/j.phrs.2024.107155_bib141","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/07315724.2017.1392264","article-title":"Comparison of calorie-restricted diet and resveratrol supplementation on anthropometric indices, metabolic parameters, and serum sirtuin-1 levels in patients with nonalcoholic fatty liver disease: a randomized controlled clinical trial","volume":"37","author":"Asghari","year":"2018","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.phrs.2024.107155_bib142","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.nutres.2014.09.005","article-title":"Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease","volume":"34","author":"Faghihzadeh","year":"2014","journal-title":"Nutr. Res"},{"key":"10.1016\/j.phrs.2024.107155_bib143","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1017\/S0007114515002433","article-title":"The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study","volume":"114","author":"Faghihzadeh","year":"2015","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.phrs.2024.107155_bib144","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.cgh.2014.02.024","article-title":"Resveratrol does not benefit patients with nonalcoholic fatty liver disease","volume":"12","author":"Chachay","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2024.107155_bib145","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/dom.13268","article-title":"Effects of resveratrol supplementation on liver fat content in overweight and insulin-resistant subjects: a randomized, double-blind, placebo-controlled clinical trial","volume":"20","author":"Kantartzis","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.phrs.2024.107155_bib146","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1111\/dom.13409","article-title":"No effect of resveratrol on VLDL-TG kinetics and insulin sensitivity in obese men with nonalcoholic fatty liver disease","volume":"20","author":"Poulsen","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.phrs.2024.107155_bib147","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3109\/00365521.2015.1107620","article-title":"Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease","volume":"51","author":"Heeb\u00f8ll","year":"2016","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.phrs.2024.107155_bib148","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12872-022-02637-2","article-title":"Effect of resveratrol supplementation on hepatic steatosis and cardiovascular indices in overweight subjects with type 2 diabetes: a double-blind, randomized controlled trial","volume":"22","author":"Ali Sangouni","year":"2022","journal-title":"BMC Cardiovasc Disord."},{"key":"10.1016\/j.phrs.2024.107155_bib149","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/ajcn\/nqab250","article-title":"The effects of resveratrol supplementation in patients with type 2 diabetes, metabolic syndrome, and nonalcoholic fatty liver disease: an umbrella review of meta-analyses of randomized controlled trials","volume":"114","author":"Zeraattalab-Motlagh","year":"2021","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.phrs.2024.107155_bib150","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/mnfr.200500003","article-title":"Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats","volume":"49","author":"Wenzel","year":"2005","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.phrs.2024.107155_bib151","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1021\/acs.biomac.1c01360","article-title":"Construction of glycogen-based nanoparticles loaded with resveratrol for the alleviation of high-fat diet-induced nonalcoholic fatty liver disease","volume":"23","author":"Li","year":"2022","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.phrs.2024.107155_bib152","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jconrel.2019.06.023","article-title":"The hepatic-targeted, resveratrol loaded nanoparticles for relief of high fat diet-induced nonalcoholic fatty liver disease","volume":"307","author":"Teng","year":"2019","journal-title":"J. Control Release"},{"key":"10.1016\/j.phrs.2024.107155_bib153","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1039\/D0FO03320K","article-title":"Pterostilbene modifies triglyceride metabolism in hepatic steatosis induced by high-fat high-fructose feeding: a comparison with its analog resveratrol","volume":"12","author":"G\u00f3mez-Zorita","year":"2021","journal-title":"Food Funct."},{"key":"10.1016\/j.phrs.2024.107155_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154561","article-title":"Pterostilbene alleviated NAFLD via AMPK\/mTOR signaling pathways and autophagy by promoting Nrf2","volume":"109","author":"Shen","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phrs.2024.107155_bib155","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202300370","article-title":"Pterostilbene enhances thermogenesis and mitochondrial biogenesis by activating the SIRT1\/PGC-1\u03b1\/SIRT3 pathway to prevent western diet-induced obesity","volume":"67","author":"Koh","year":"2023","journal-title":"Mol. Nutr. Food Res"},{"key":"10.1016\/j.phrs.2024.107155_bib156","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1021\/acs.jafc.9b04259","article-title":"Pterostilbene improves hepatic lipid accumulation via the MiR-34a\/Sirt1\/SREBP-1 pathway in fructose-fed rats","volume":"68","author":"Wu","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.phrs.2024.107155_bib157","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1111\/bph.14573","article-title":"Pterostilbene prevents hepatocyte epithelial-mesenchymal transition in fructose-induced liver fibrosis through suppressing miR-34a\/Sirt1\/p53 and TGF-\u03b21\/Smads signalling","volume":"176","author":"Song","year":"2019","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.phrs.2024.107155_bib158","article-title":"Comparative effects of pterostilbene and its parent compound resveratrol on oxidative stress and inflammation in steatohepatitis induced by high-fat high-fructose feeding","volume":"9","author":"G\u00f3mez-Zorita","year":"2020","journal-title":"Antioxid. (Basel)"},{"key":"10.1016\/j.phrs.2024.107155_bib159","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/hep.32778","article-title":"Nicotinamide riboside and pterostilbene reduces markers of hepatic inflammation in NAFLD: a double-blind, placebo-controlled clinical trial","volume":"78","author":"Dellinger","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2024.107155_bib160","doi-asserted-by":"crossref","DOI":"10.3390\/nu11030541","article-title":"Dietary polyphenols protect against oleic acid-induced steatosis in an in vitro model of NAFLD by modulating lipid metabolism and improving mitochondrial function","volume":"11","author":"Rafiei","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2024.107155_bib161","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3417306","article-title":"Quercetin improves glucose and lipid metabolism of diabetic rats: involvement of akt signaling and SIRT1","volume":"2017","author":"Peng","year":"2017","journal-title":"J. Diabetes Res"},{"key":"10.1016\/j.phrs.2024.107155_bib162","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.fct.2012.10.030","article-title":"Dietary quercetin ameliorates nonalcoholic steatohepatitis induced by a high-fat diet in gerbils","volume":"52","author":"Ying","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.phrs.2024.107155_bib163","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/biof.1724","article-title":"Quercetin prevents cadmium chloride-induced hepatic steatosis and fibrosis by downregulating the transcription of miR-21","volume":"47","author":"Alshammari","year":"2021","journal-title":"Biofactors"},{"key":"10.1016\/j.phrs.2024.107155_bib164","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1002\/ptr.7569","article-title":"The construction of preclinical evidence for the treatment of liver fibrosis with quercetin: a systematic review and meta-analysis","volume":"36","author":"Guo","year":"2022","journal-title":"Phytother. Res."},{"key":"10.1016\/j.phrs.2024.107155_bib165","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6678662","article-title":"The therapeutic effects and mechanisms of quercetin on metabolic diseases: pharmacological data and clinical evidence","volume":"2021","author":"Yi","year":"2021","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.phrs.2024.107155_bib166","doi-asserted-by":"crossref","DOI":"10.3390\/nu11112702","article-title":"Curcumin ameliorates nonalcoholic fatty liver disease through inhibition of O-GlcNAcylation","volume":"11","author":"Lee","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2024.107155_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2021.111464","article-title":"Patchouli alcohol ameliorates skeletal muscle insulin resistance and NAFLD via AMPK\/SIRT1-mediated suppression of inflammation","volume":"538","author":"Pyun","year":"2021","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.phrs.2024.107155_bib168","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.2147\/DMSO.S437865","article-title":"Biological role and related natural products of SIRT1 in nonalcoholic fatty liver","volume":"16","author":"Meng","year":"2023","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.phrs.2024.107155_bib169","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nature06261","article-title":"Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes","volume":"450","author":"Milne","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2024.107155_bib170","article-title":"11\u03b2-HSD1 inhibitor alleviates non-alcoholic fatty liver disease by activating the AMPK\/SIRT1 signaling pathway","volume":"14","author":"Chen","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2024.107155_bib171","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.3892\/ijmm.2016.2799","article-title":"Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db\/db mice","volume":"38","author":"Kong","year":"2016","journal-title":"Int J. Mol. Med."},{"key":"10.1016\/j.phrs.2024.107155_bib172","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.molmet.2016.11.002","article-title":"Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1","volume":"6","author":"Zhang","year":"2017","journal-title":"Mol. Metab."},{"key":"10.1016\/j.phrs.2024.107155_bib173","doi-asserted-by":"crossref","DOI":"10.3390\/nu13030933","article-title":"The role of resveratrol in liver disease: a comprehensive review from in vitro to clinical trials","volume":"13","author":"Izzo","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2024.107155_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/j.sjbs.2023.103717","article-title":"Pterostilbene induces apoptosis in hepatocellular carcinoma cells: biochemical, pathological, and molecular markers","volume":"30","author":"Khalil","year":"2023","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.phrs.2024.107155_bib175","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1002\/ptr.7104","article-title":"Quercetin as a protective agent for liver diseases: a comprehensive descriptive review of the molecular mechanism","volume":"35","author":"Zhao","year":"2021","journal-title":"Phytother. Res"},{"key":"10.1016\/j.phrs.2024.107155_bib176","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1829346","article-title":"Resveratrol exerts antitumor effects by downregulating CD8(+)CD122(+) Tregs in murine hepatocellular carcinoma","volume":"9","author":"Zhang","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.phrs.2024.107155_bib177","doi-asserted-by":"crossref","DOI":"10.3390\/nu11122875","article-title":"Antitumor effects of quercetin in hepatocarcinoma in vitro and in vivo models: a systematic review","volume":"11","author":"Fern\u00e1ndez-Palanca","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2024.107155_bib178","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106925","article-title":"Natural products in non-alcoholic fatty liver disease (NAFLD): novel lead discovery for drug development","volume":"196","author":"Wang","year":"2023","journal-title":"Pharm. Res"},{"key":"10.1016\/j.phrs.2024.107155_bib179","first-page":"88","article-title":"Sirtuin 1 signaling and alcoholic fatty liver disease","volume":"4","author":"You","year":"2015","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"10.1016\/j.phrs.2024.107155_bib180","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.31773","article-title":"Sirtuin 2 prevents liver steatosis and metabolic disorders by deacetylation of hepatocyte nuclear factor 4\u03b1","volume":"74","author":"Ren","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2024.107155_bib181","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.redox.2018.07.011","article-title":"Therapeutic effect of Sirtuin 3 on ameliorating nonalcoholic fatty liver disease: The role of the ERK-CREB pathway and Bnip3-mediated mitophagy","volume":"18","author":"Li","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.phrs.2024.107155_bib182","doi-asserted-by":"crossref","DOI":"10.3390\/cells9051101","article-title":"EX-527 Prevents the Progression of High-Fat Diet-Induced Hepatic Steatosis and Fibrosis by Upregulating SIRT4 in Zucker Rats","volume":"9","author":"Kundu","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2024.107155_bib183","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1016\/j.molcel.2022.09.018","article-title":"Cytoplasmic SIRT6-mediated ACSL5 deacetylation impedes nonalcoholic fatty liver disease by facilitating hepatic fatty acid oxidation","volume":"82","author":"Hou","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2024.107155_bib184","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.celrep.2013.10.007","article-title":"SIRT7 represses Myc activity to suppress ER stress and prevent fatty liver disease","volume":"5","author":"Shin","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2024.107155_bib185","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jhep.2023.09.020","article-title":"SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease","volume":"80","author":"Salomone","year":"2024","journal-title":"J. Hepatol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824000999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824000999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T03:03:06Z","timestamp":1714273386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661824000999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":185,"alternative-id":["S1043661824000999"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107155","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SIRT1: Harnessing multiple pathways to hinder NAFLD","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107155"}}